This article was taken from: https://medicalxpress.com/news/2017-12-arthritis-drug-advanced-skin-cancer.html By: University of East Anglia Treatment for the most deadly form of skin cancer could be more effective if combined with a well-known drug for rheumatoid arthritis, new research has shown. The study, by scientists at the University of East Anglia (UEA), found that in mice, using the two treatments together…
This article was taken from: http://www.independent.co.uk/news/health/nhs-brexit-overseas-doctors-staffing-hospitals-nurses-leave-eu-withdrawal-healthcare-a8118441.html By: Alex Matthews-King Health Correspondent Not enough doctors to match growing demand, with some areas reliant on overseas recruits for more than two in five medical roles The NHS faces a crisis if the UK becomes a less attractive place for foreign doctors after Brexit, the General Medical Council has warned. Almost half of doctors…
This article was taken from: http://www.telegraph.co.uk/news/2017/12/19/every-nhs-trust-told-bring-early-warning-checks-war-sepsis/ By: Laura Donnelly, health editor Every NHS hospital should adopt an early warning system to prevent almost 2,000 needless deaths a year, including cases of sepsis, officials say. All trusts have been asked to introduce consistent checks, amid warnings that the safety of millions of patients is at stake. Sir Bruce Keogh,…
This article was taken from: https://www.theguardian.com/society/2017/dec/19/nhs-hospitals-unable-fill-thousands-vacant-posts-labour-says By: Denis CampbellHealth policy editor Understaffing so acute almost one in four posts at some trusts in England are vacant, freedom of information requests show The NHS is short of more than 100,000 staff, and some hospitals are struggling to fill as many as 1,600 vacancies, according to new research that has sparked…
This article was taken from: http://www.independent.co.uk/news/health/milestone-ovarian-cancer-drug-approved-uk-chemotherapy-treatment-a8115101.html By: Alex Matthews-King Health Correspondent Once-a-day pill gives women an extra year and a half before the disease returns A pill which has the potential to buy an extra 16 months of life for women with ovarian cancer has been dubbed a “milestone” treatment, after it was licensed for use in the UK. The once-daily pill Niraparib is…